Table 1 Study characteristics included in the systematic review and meta-analysis
Authors | Region | Study area | Study design | Sample size | Prevalence | Response rate | Quality |
|---|---|---|---|---|---|---|---|
Jebessa S et al. [12] | SNNPR | Attat | cross-sectional | 3722 | 30.494 | 100% | Low risk |
Bizuneh A, Ayana G [13] | SNNPR | Addis Ababa | cross-sectional | 2345 | 24.819 | 100% | Low risk |
Amanuel G et al. [18] | Tigray | Mekelle | cross-sectional | 9348 | 31.14 | 100 | Low risk |
Tesfaye T et al. [19] | SNNPR | Sidama | cross-sectional | 469 | NA | 100 | Low risk |
Tenaw Z, et al. [20] | SNNPR | Hawassa | cross-sectional | 300 | 49.333 | 98.7 | Low risk |
Abayneh A [21] | Amhara | Gondar | cross-sectional | 323 | 29.721 | 100 | Low risk |
Almaz H et al. [22] | SNNPR | Hawassa | cross-sectional | 3195 | 17.089 | 100 | Low risk |
Ayodeji O et al. [23] | Addis Ababa | Addis Ababa | cross-sectional | 411 | 63.747 | 100 | Low risk |
Hordofa G, Ashenafi S [24] | SNNPR | Mizan Aaman | cross-sectional | 342 | 21.053 | 100 | Low risk |
Melaku K et al. [25] | Amhara | Finote selam | cross-sectional | 2267 | 11.028 | 100 | Low risk |
Bago BJ et al. [26] | Hawassa | Hawassa | cross-sectional | 422 | 35.071 | 98 | Low risk |
Abebe et al. [27] | Amhara | Bahirdar | cross-sectional | 2967 | 24.368 | 100 | Low risk |
Hiwot et al. [28] | Addis Ababa | Addis Ababa | cross-sectional | 298 | 38.255 | 100 | Low risk |
Alemayeu et al. [29] | Harar | Harar | cross-sectional | 422 | NA | 100 | Low risk |
Bayou YT et al. [30] | Addis Ababa | Addis Ababa | cross-sectional | 835 | 19.281 | 100 | Low risk |
Wondie et al. [31] | Amhara | Dessie | cross-sectional | 512 | 47.656 | 98.4 | Low risk |
Tsega et al. [32] | Harar | Harar | cross-sectional | 601 | 34.276 | 95.4 | Low risk |
Geremew et al. [33] | SNNPR | Attat | cross-sectional | 5611 | 27.571 | 100 | Low risk |
Solomon et al. [34] | Oromia | Chiro | cross-sectional | 407 | 18.182 | 100 | Low risk |
Taye and Yuya [35] | Oromia | Jimma | cross-sectional | 388 | 28.351 | 100 | Low risk |
Mengesha et al [36] | Tigray | Mekelle | cross-sectional | 338 | NA | 100 | Low risk |
Gebre S, et al. [37] | Tigray | Dansha | cross-sectional | 749 | 13.218 | 100 | Low risk |
Melese et al. [38] | Amhara | Woldia | cross-sectional | 433 | 30.947 | 100 | Low risk |